Application Nr Approved Date Route Status External Links
NDA208462 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ninlaro Is Indicated In Combination With Lenalidomide And Dexamethasone For The Treatment Of Patients With Multiple Myeloma Who Have Received At Least One Prior Therapy. Ninlaro Is A Proteasome Inhibitor Indicated In Combination With Lenalidomide And Dexamethasone For The Treatment Of Patients With Multiple Myeloma Who Have Received At Least One Prior Therapy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ixazomib Citrate

Comments